Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Schedule of Potentially Dilutive Securities (Details)

v3.20.1
Net Loss Per Share - Schedule of Potentially Dilutive Securities (Details) - shares
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities 6,843,900 4,910,000
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities 1,221,000 2,268,900
Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities 1,665,000 125,000
Convertible Notes Payable, Including Accrued Interest [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities 3,957,900 2,516,100